Best JNM Podcasts (2025)

1
SPARC: Overarching Framework for PSMA PET Reporting 21:46

Play Pause

10d ago21:46

21:46

Data tells us that nuclear medicine has made extraordinary strides in curing prostate cancer, especially with the use of PSMA PET. But how are we reporting on PSMA, and how can this data be standardized globally? SPARC could be the answer! SPARC stands for "Standardized PSMA Reporting Criteria," and it's been initiated because of the widespread use…

1
PET-Guided Radiotherapy: Reflections? 23:06

1M ago23:06

23:06

Being able to personalize a patient's treatment is one of the cornerstones of nuclear medicine, but how are we able to do that? PET-Guided radiotherapy is one answer. In addition to staging and defining a disease, PET imaging can also give providers important information about what's going on in the body while a patient is undergoing their treatmen…

1
Biomarkers in Prostate Cancer: What's in the Blood? 29:52

3M ago29:52

29:52

Biomarkers: what are they and how are they useful in the diagnosis and treatment of prostate cancer? On this episode of the JNM Podcast, our panel of experts explores what they call a "liquid biopsy:" using biomarkers shed by cancer cells into the bloodstream to gain vital insights about the disease and its progression, identify candidates who woul…

1
From Isotope to Impact: 211At 28:32

4M ago28:32

28:32

Is it really happening? Astatine-211 is a promising new radionuclide being further developed and researched for the treatment of cancer. It is a short half-life alpha-emitter that's attracting more interest from the nuclear medicine community as investors take notice of its potential and production capacity improves. So where will 211At be by 2030?…

1
Live from New Orleans: JNM Podcast with Johannes Czernin and Anna Karmann 25:20

5M ago25:20

25:20

In this live episode of The JNM Podcast, Johannes Czernin interviews Anna Karmann to talk about the various career trajectories available in nuclear medicine.By JNM

1
Live from New Orleans: JNM Podcast with David Mankoff, Hossein Jadvar, and Todd Peterson 15:25

5M ago15:25

15:25

The JNM Podcast is back and live from New Orleans. Guests David Mankoff, Hossein Jadvar, and Todd Peterson answer the question: "Can society-based journals compete with corporate-based publications?"By JNM

1
Live from New Orleans: JNM Podcast with Richard Wahl 19:27

5M ago19:27

19:27

You love the column, now hear it in person! Throughout the meeting, JNM Editor in Chief Johannes Czernin will host Discussions with Leaders to talk about the most important and exciting topics in nuclear medicine. First up is Richard Wahl, MD.By JNM

1
Understanding Metabolic PET Markers Beyond SUV 28:13

8M ago28:13

28:13

Standardized uptake values (SUV) measure a patient's response to nuclear medicine therapy. But what other markers of success are there, and do these markers and the interpretation of them vary depending on the disease being imaged? Sally Barrington, MD, works specifically on lymphoma and shares her expertise on what markers of success and criteria …

1
PSMA PET: From Adolescence to Adulthood 31:31

10M ago31:31

31:31

Is PSMA becoming so regularly used that it's...boring? Not according to this lively discussion. Join us for episode 9 of the JNM Podcast, where host Ken Herrmann discusses the state of PSMA PET with experts Thomas Hope, Oliver Sartor, and Wolfgang Fendler. The panel talks about PSMA PET in clinical trials vs. real-life disease management, appropria…

1
Revolutionizing Cardiovascular Imaging with Flurpiridaz 34:20

11M ago34:20

34:20

The JNM Podcast is back in 2025! Join Ken Herrmann, MD, and co-moderator Frank Bengel, MD, for an episode on cardiovascular perfusion imaging. In the U.S., SPECT imaging makes up five to six million studies per year. But PET studies make up just 2.2 million, and only 7%, or 150,000 of those, are cardiac PET imaging. But that may be about to change.…

1
Social Media in (Nuclear) Medicine 21:57

1y ago21:57

21:57

Get ready for an episode that's a bit...meta. In Episode 7, our host Ken Herrmann is joined by the podcasters behind GU Cast: Declan Murphy, FRACS, FRCS, and Renu Eapen, MBBS, FRACS. Together with Wolfgang Weber, MD, PhD, they discuss how social media has shaped the landscape of medicine - from how we get medical news, to sharing new research to in…

1
Bringing PRRT to First Line: NETTER-2 28:48

1y ago28:48

28:48

Join us for episode 6 of the JNM podcast. Moderator Ken Herrmann, MD is joined by Simron Singh, MD and Lisa Bodei, MD, PhD to discuss NETTER-2. NETTER-2 was the first trial to examine radioligand therapy as a first-line therapy for cancers, as opposed to waiting until later stages. Our panelists discuss the results of this trial and its implication…

1
Healthcare Systems Readiness: What is Limiting the RLT Scale-up? 28:25

1+ y ago28:25

28:25

Radioligand therapy (RLT) targets cancer cells with radiation while minimizing impact on surrounding healthy tissue. In this episode of JNM Podcast, our panelists discuss training, access, production capacity, and everything else that is necessary to make RLT more widely available to the patients who need it. Moderator: Ken Herrmann, MD (Universitä…

1
The Standard of Care for Metastatic Prostate Cancer 34:00

1+ y ago34:00

34:00

The VISION Trial is the first-in-its-field study to use radiopharmaceuticals that directly target prostate cancer tumors. Hear from one of the lead researchers on this ground-breaking study as he discusses how the trial has opened up a completely new field of study in prostate cancer research and shaped the future of nuclear medicine therapy in com…

1
Advances in Dementia Imaging: Insights from Experts 29:07

1+ y ago29:07

29:07

The Journal of Nuclear Medicine presents a new podcast on advances in dementia imaging. Panelists discuss the importance of amyloid and tau PET imaging in dementia diagnosis and treatment, highlighting their roles in clinical trials and future therapies. They emphasize the significance of early detection and the potential for personalized medicine …

1
Alpha is More Than Just Ac-225: Pb-212 21:19

1+ y ago21:19

21:19

This month's episode of the JNM Podcast takes the discussion of Pb-212 worldwide! Researchers from the UK, Australia, and North America discuss the logistics of using lead-212 as a radionuclide imaging agent. From availability to production to transportation, Pb-212 presents both great opportunities and great challenges. Moderator Ken Herrmann, MD,…

1
The Future of FAPI Therapy 43:24

1+ y ago43:24

43:24

The Journal of Nuclear Medicine presents a new podcast on FAPI-directed theranostics for cancer diagnosis and treatment. Join moderator Ken Herrmann (Universitätsmedizin) and panelists Andrew Scott (Austin Health), Katharina Lückerath (Universitätsmedizin) and Shadi Esfahadi (Mass General Hospital) as they delve into the history of FAP, discuss cha…

1
JnM Sports Radio: NY JETS SMOKE REDSKINS, GASE TO STAY, CESPEDES, ASTROS CHEATING SCANDAL!!! 11:23

6y ago11:23

11:23

Today's Podcast I discuss the Jets blow out win over the Washington Redskins. Also go over Christopher Johnson giving New York Jets Head Coach Adam Gase a ringing endorsement after beating the NY Giants saying he will stay the rest of the season and in 2020 despite having a 2-7 record. The Astros Cheating Scandal with stealing signs using technolog…